Kristen Kluska
Stock Analyst at Cantor Fitzgerald
(4.83)
# 453
Out of 4,685 analysts
386
Total ratings
50%
Success rate
23.8%
Average return
Main Sectors:
Stocks Rated by Kristen Kluska
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLDB Solid Biosciences | Maintained: Buy | $16 → $26 | $9.20 | +182.61% | 3 | Aug 27, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $96 → $103 | $26.49 | +288.83% | 17 | Aug 20, 2026 | |
| RNA Atrium Therapeutics | Maintained: Buy | $25 | $12.84 | +94.70% | 2 | Aug 17, 2026 | |
| CAPR Capricor Therapeutics | Upgraded: Buy | $3.5 → $28 | $6.65 | +321.05% | 16 | Aug 14, 2026 | |
| PTCT PTC Therapeutics | Maintained: Buy | $130 | $71.70 | +81.31% | 25 | Aug 12, 2026 | |
| MNPR Monopar Therapeutics | Downgraded: Hold | $109 → $119 | $113.04 | +5.27% | 10 | Aug 12, 2026 | |
| CDXS Codexis | Maintained: Buy | $11 | $1.56 | +605.13% | 11 | Aug 11, 2026 | |
| TSHA Taysha Gene Therapies | Maintained: Buy | $19 | $5.95 | +219.33% | 20 | Aug 11, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | $26.37 | $9.31 | +183.19% | 11 | Aug 11, 2026 | |
| CLDX Celldex Therapeutics | Reiterated: Buy | $61 | $41.95 | +45.41% | 27 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $8.84 | +81.00% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 | $18.10 | +16.02% | 28 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $12 | $9.47 | +26.72% | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $25 | $11.32 | +120.85% | 10 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $38 → $43 | $42.58 | +0.99% | 14 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $14.02 | +242.37% | 9 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $63 → $67 | $48.27 | +38.80% | 10 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $4.25 | +158.82% | 5 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 23.00 | kr 7.16 | +221.23% | 1 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $48.62 | - | 12 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.3189 | +840.73% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $78.84 | +58.55% | 17 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $4.84 | +292.56% | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $24 | $3.74 | +541.71% | 8 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $0.5015 | +298.80% | 9 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $5.99 | +367.84% | 11 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $9.58 | +202.71% | 7 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $4.22 | +231.75% | 8 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $7 | $0.6048 | n/a | 4 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $3.61 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.07 | n/a | 3 | Feb 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $20 | $0.7564 | n/a | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $14.25 | n/a | 3 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $1.04 | n/a | 3 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $31.04 | n/a | 1 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.91 | n/a | 2 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 → $28 | $0.075 | n/a | 2 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $20 | $0.0001 | n/a | 3 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.147 | n/a | 4 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.25 → $10 | $1.43 | n/a | 3 | Dec 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $11 | $0.5231 | n/a | 2 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $4.27 | n/a | 1 | Dec 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $1.35 | n/a | 6 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.5935 | n/a | 4 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $0.001 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $0.6008 | n/a | 1 | Nov 30, 2020 |
Solid Biosciences
Aug 27, 2026
Maintained: Buy
Price Target: $16 → $26
Current: $9.20
Upside: +182.61%
Ultragenyx Pharmaceutical
Aug 20, 2026
Maintained: Buy
Price Target: $96 → $103
Current: $26.49
Upside: +288.83%
Atrium Therapeutics
Aug 17, 2026
Maintained: Buy
Price Target: $25
Current: $12.84
Upside: +94.70%
Capricor Therapeutics
Aug 14, 2026
Upgraded: Buy
Price Target: $3.5 → $28
Current: $6.65
Upside: +321.05%
PTC Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $130
Current: $71.70
Upside: +81.31%
Monopar Therapeutics
Aug 12, 2026
Downgraded: Hold
Price Target: $109 → $119
Current: $113.04
Upside: +5.27%
Codexis
Aug 11, 2026
Maintained: Buy
Price Target: $11
Current: $1.56
Upside: +605.13%
Taysha Gene Therapies
Aug 11, 2026
Maintained: Buy
Price Target: $19
Current: $5.95
Upside: +219.33%
Eupraxia Pharmaceuticals Inc.
Aug 11, 2026
Reiterated: Buy
Price Target: $26.37
Current: $9.31
Upside: +183.19%
Celldex Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $61
Current: $41.95
Upside: +45.41%
Aug 6, 2026
Reiterated: Buy
Price Target: $16
Current: $8.84
Upside: +81.00%
Aug 5, 2026
Maintained: Hold
Price Target: $21
Current: $18.10
Upside: +16.02%
Aug 5, 2026
Maintained: Hold
Price Target: $30 → $12
Current: $9.47
Upside: +26.72%
Aug 5, 2026
Maintained: Buy
Price Target: $34 → $25
Current: $11.32
Upside: +120.85%
Aug 4, 2026
Maintained: Hold
Price Target: $38 → $43
Current: $42.58
Upside: +0.99%
Jul 16, 2026
Maintained: Buy
Price Target: $48
Current: $14.02
Upside: +242.37%
Jul 9, 2026
Maintained: Buy
Price Target: $63 → $67
Current: $48.27
Upside: +38.80%
Jun 25, 2026
Maintained: Buy
Price Target: $11
Current: $4.25
Upside: +158.82%
Jun 25, 2026
Initiated Coverage: Buy
Price Target: kr 23.00
Current: kr 7.16
Upside: +221.23%
Jun 17, 2026
Upgraded: Buy
Price Target: n/a
Current: $48.62
Upside: -
May 12, 2026
Maintained: Buy
Price Target: $3
Current: $0.3189
Upside: +840.73%
May 12, 2026
Maintained: Buy
Price Target: $125
Current: $78.84
Upside: +58.55%
Mar 30, 2026
Maintained: Buy
Price Target: $19
Current: $4.84
Upside: +292.56%
Mar 19, 2026
Maintained: Buy
Price Target: $15 → $24
Current: $3.74
Upside: +541.71%
Mar 10, 2026
Maintained: Hold
Price Target: $2
Current: $0.5015
Upside: +298.80%
Feb 23, 2026
Maintained: Buy
Price Target: $28
Current: $5.99
Upside: +367.84%
Jan 13, 2026
Maintained: Buy
Price Target: $29
Current: $9.58
Upside: +202.71%
Nov 21, 2025
Maintained: Buy
Price Target: $14
Current: $4.22
Upside: +231.75%
Jul 1, 2024
Maintained: Buy
Price Target: $6 → $7
Current: $0.6048
Upside: n/a
May 13, 2024
Rated: Buy
Price Target: n/a
Current: $3.61
Upside: n/a
Feb 4, 2024
Maintained: Buy
Price Target: $6
Current: $1.07
Upside: n/a
Aug 30, 2023
Downgraded: Hold
Price Target: $4 → $20
Current: $0.7564
Upside: n/a
Aug 28, 2023
Reiterated: Buy
Price Target: $23
Current: $14.25
Upside: n/a
Jun 28, 2023
Maintained: Buy
Price Target: $27
Current: $1.04
Upside: n/a
Jun 26, 2023
Reiterated: Buy
Price Target: $17
Current: $31.04
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $1.91
Upside: n/a
May 15, 2023
Maintained: Buy
Price Target: $3.5 → $28
Current: $0.075
Upside: n/a
Mar 16, 2023
Downgraded: Hold
Price Target: $28 → $20
Current: $0.0001
Upside: n/a
Mar 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Mar 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.147
Upside: n/a
Dec 21, 2022
Maintained: Hold
Price Target: $4.25 → $10
Current: $1.43
Upside: n/a
Aug 4, 2022
Downgraded: Hold
Price Target: $14 → $11
Current: $0.5231
Upside: n/a
Dec 29, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $4.27
Upside: n/a
Sep 28, 2021
Reiterated: Hold
Price Target: $4
Current: $1.35
Upside: n/a
May 12, 2021
Maintained: Buy
Price Target: $10
Current: $0.5935
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: $22
Current: $0.001
Upside: n/a
Nov 30, 2020
Initiated Coverage: Buy
Price Target: $9
Current: $0.6008
Upside: n/a